Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4793054
Max Phase: Preclinical
Molecular Formula: C35H53N5O6S
Molecular Weight: 671.91
Molecule Type: Unknown
Associated Items:
ID: ALA4793054
Max Phase: Preclinical
Molecular Formula: C35H53N5O6S
Molecular Weight: 671.91
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCO[C@H](C[C@H](C(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H]1CCCCN1C)c1nc(C(=O)N[C@@H](Cc2ccccc2)C[C@H](C)C(=O)O)cs1
Standard InChI: InChI=1S/C35H53N5O6S/c1-8-46-30(20-29(22(2)3)40(7)34(43)24(5)36-32(42)28-16-12-13-17-39(28)6)33-38-27(21-47-33)31(41)37-26(18-23(4)35(44)45)19-25-14-10-9-11-15-25/h9-11,14-15,21-24,26,28-30H,8,12-13,16-20H2,1-7H3,(H,36,42)(H,37,41)(H,44,45)/t23-,24-,26+,28+,29+,30+/m0/s1
Standard InChI Key: DUHZOWVLTXFLTK-WIKACDFQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 671.91 | Molecular Weight (Monoisotopic): 671.3717 | AlogP: 4.53 | #Rotatable Bonds: 17 |
Polar Surface Area: 141.17 | Molecular Species: ACID | HBA: 8 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.21 | CX Basic pKa: 7.25 | CX LogP: 1.60 | CX LogD: 1.31 |
Aromatic Rings: 2 | Heavy Atoms: 47 | QED Weighted: 0.22 | Np Likeness Score: -0.17 |
1. Courter JR,Hamilton JZ,Hendrick NR,Zaval M,Waight AB,Lyon RP,Senter PD,Jeffrey SC,Burke PJ. (2020) Structure-activity relationships of tubulysin analogues., 30 (14): [PMID:32527543] [10.1016/j.bmcl.2020.127241] |
Source(1):